Evolent Health amends conversion rate and redeems $24.3M convertible notes

Evolent Health, Inc.

Corrected conversion rate to 55.5198 shares per $1,000 principal (from 54.8667).
Redemption of 3.50% Convertible Senior Notes due 2024 on Oct 13, 2023 at 100% par plus interest.
Outstanding principal $24.3 million as of Aug 2, 2023; funded via cash on hand.
Holders may convert before redemption; Company will use Physical Settlement and pay cash for fractional shares.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.